Reporting parties
Subject security
Symbol
EYPT
Shares outstanding
68,854,042 shares
Ownership signal
SEC evidence
Form type
SCHEDULE 13G/A
Filing time
08 Jul 2025, 07:30:44 UTC
Event date
30 Jun 2025
SEC filing
View on sec.gov

Key filing fact

FEDERATED HERMES, INC. disclosed 6.7% ownership in EYEPOINT PHARMACEUTICALS, INC. COMMON STOCK (EYPT) on 30 Jun 2025.

Key facts

  • FEDERATED HERMES, INC. filed SCHEDULE 13G/A for EYEPOINT PHARMACEUTICALS, INC. COMMON STOCK (EYPT).
  • Disclosed ownership: 6.7%.
  • Date of event: 30 Jun 2025.

Change

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 08 Jul 2025, 07:30.

Research use

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting persons

Reporting managers (5)

Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Federated Hermes, Inc. 6.7% 4,599,450 4,599,450 0 /s/J. Christopher Donahue J. Christopher Donahue, as President of Federated Hermes, Inc.
Voting Shares Irrevocable Trust 6.7% 4,599,450 4,599,450 0 /s/Thomas R. Donahue Thomas R. Donahue, as Trustee of Voting Shares Irrevocable Trust
Thomas R. Donahue 6.7% 4,599,450 0 4,599,450 /s/Thomas R. Donahue Thomas R. Donahue
Ann C. Donahue 6.7% 4,599,450 0 4,599,450 /s/Ann C. Donahue Ann C. Donahue
J. Christopher Donahue 6.7% 4,599,450 0 4,599,450 /s/J. Christopher Donahue J. Christopher Donahue
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .